Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema

BACKGROUND: Diabetic macular edema (DME) is a major cause of vision loss in diabetics worldwide. Anti-vascular endothelial growth factor (anti-VEGF) agents have become the mainstay of treatment of vision loss due to DME. Long-term effects of these agents on the macular perfusion (MP) are a current c...

Descripción completa

Detalles Bibliográficos
Autores principales: Elnahry, Ayman G., Abdel-Kader, Ahmed A., Habib, Ahmed E., Elnahry, Gehad A., Raafat, Karim A., Elrakhawy, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536789/
https://www.ncbi.nlm.nih.gov/pubmed/32427087
http://dx.doi.org/10.2174/1574887115666200519073704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536789/
https://www.ncbi.nlm.nih.gov/pubmed/32427087
http://dx.doi.org/10.2174/1574887115666200519073704

Ejemplares similares